Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.

[1]  E. Canalis.  Glucocorticoid-induced osteoporosis , 2000, Oxford Textbook of Endocrinology and Diabetes 3e.

[2]  Olof Johnell,et al.  A Meta‐Analysis of Prior Corticosteroid Use and Fracture Risk , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  R. Capozza,et al.  Biphasic dose-response curves of cortisol effects on rat diaphyseal bone biomechanics , 2004, Calcified Tissue International.

[4]  M. Hochberg,et al.  Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs. , 2003, Archives of internal medicine.

[5]  C. Cooper,et al.  Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. , 2003, Arthritis and rheumatism.

[6]  C. Cooper,et al.  The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis , 2002, Osteoporosis International.

[7]  J. Reginster,et al.  The Use of Placebo-Controlled and Non-inferiority Trials for the Evaluation of New Drugs in the Treatment of Postmenopausal Osteoporosis , 2002, Osteoporosis International.

[8]  M. Hochberg,et al.  Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1996 .

[9]  C. Cooper,et al.  Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. , 2000, Rheumatology.

[10]  D. Reid,et al.  Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid‐Induced Osteoporosis in Men and Women: A Randomized Trial , 2000 .

[11]  C. Cooper,et al.  Use of Oral Corticosteroids and Risk of Fractures , 2000 .

[12]  P. Selby,et al.  Corticosteroids Do Not Alter the Threshold for Vertebral Fracture , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  L Abenhaim,et al.  Use of oral corticosteroids in the United Kingdom. , 2000, QJM : monthly journal of the Association of Physicians.

[14]  S. Wallach,et al.  Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. , 1999, Arthritis and rheumatism.

[15]  R. Weinstein,et al.  New Developments in the Pathogenesis and Treatment of Steroid‐Induced Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  S. Epstein.  Immunosuppressant drugs and bone disease: a clinician's perspective. , 1998, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[17]  C. G. Bellows,et al.  Osteoprogenitor cells in cell populations derived from mouse and rat calvaria differ in their response to corticosterone, cortisol, and cortisone. , 1998, Bone.

[18]  Jacques P. Brown,et al.  Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .

[19]  E. Shane,et al.  Osteoporosis after Organ Transplantation * * Access the Journal Club discussion of this paper at: , 1998 .

[20]  I. Reid.  Glucocorticoid osteoporosis--mechanisms and management. , 1997, European journal of endocrinology.

[21]  J. Reginster,et al.  Recommendations for the Registration of Agents Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1996, Calcified Tissue International.

[22]  T. Wronski,et al.  Skeletal response to corticosteroid deficiency and excess in growing male rats. , 1996, Bone.

[23]  J. Adachi.  Corticosteroid-induced osteoporosis. , 1996, Drug and therapeutics bulletin.

[24]  P. V. van Riel,et al.  Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis , 1993, Annals of Internal Medicine.

[25]  J. Montserrat,et al.  Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. , 1991, Thorax.

[26]  G. Rizzato,et al.  Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis. , 1988, Sarcoidosis.